1. Centers for Disease Control and Prevention. Biological and Chemical Terrorism: Strategic Plan for Preparedness and Response. Recommendations of the CDC Strategic Planning Workgroup. Morbidity and Mortality Weekly Report, 49(RR04):1–14, April 21, 2000.
2. Franz, D, Jahrling, PB, Friedlander, AM, et al. Clinical Recognition and Management of Patients Exposed to Biological Warfare Agents. Journal of the American Medical Association, 278(5):399–411, 1997.
3. Centers for Disease Control and Prevention. Recognition of Illness Associated with the Intentional Release of a Biologic Agent. Morbidity and Mortality Weekly Report, 50(41):893–897, 2001.
4. Inglesby, TV, O’Toole, T, Henderson, DA. Anthrax as a Biological Weapon, 2002. Updated Recommendations for Management. JAMA, 287(17):2236–2252, 2002.
5. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a Biological Weapon. Medical and Public Health Management. JAMA, 281(18):1735–1745, 1999. Also available at http://www.bt.cdc.gov (last accessed 4/15/06).